So for nearly 4 years we could’ve been making $$$ instead of the massive dilution of multiple CR ??? Even at half price would’ve ’eased the squeeze…’ Given that the EAP has serviced the GVHD cohort, the FDA have received very little pressure from that cohort as a result. Hopefully they’ve thrown all the regulatory fluff at Msb and now is the time to repay the favour ?
So for nearly 4 years we could’ve been making $$$ instead of the...
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |